NFKB1 and urinary bladder neoplasm: In bladder tumors as well, the impact of NF-κB activation on tumorigenesis has been described [24] and our previous work focused on the efficacy of NF-κB blockade by DHMEQ in a mouse xenograft model of invasive bladder cancer KU-19-19 cells [10].